K Alagiakrishnan, P McCracken, and H Feldman
Postgrad Med J 2006 82: 101-105.
Correction
Dr. Kannayiram Alagiakrishnan, wishes to apologise for the omission of the competing interests statements, which were not published alongside the article. These statements are now published below:
Peter N. McCracken: In the last three years I have received grant research support from Pfizer, Eisai, Sanofi-aventis, Lundbeck Canada, Servier Canada, Janssen-Ortho, and Neurochem Inc, Syreon Corporation and Wyeth. I have served as a consultant for Pfizer, Eisai, Novartis, Lundbeck Canada, and Janssen Ortho. I have been on the Speaker's Bureau or served in CME programs with Pfizer, Eisai, Novartis, Lundbeck and Janssen Ortho. I am not a shareholder in these firms and receive no other financial or material support.
Howard Feldman: In the last three years, I have/have had a financial interest/arrangement or affiliation with the following organizations: Grant/Research Support (External):Pfizer, Eisai, Janssen, Lilly, Astra Zeneca, Sanofi Synthelabo, Glaxo Smith Kline. Consultant: Pfizer, Eisai, Novartis, Janssen, Servier, Sanofi Synthelabo, Glaxo Smith Kline, Myriad, Targacept, Lundbeck, Forest, Axonyx. Speakers’ Bureau or CME programs:Pfizer, Eisai, Janssen, Novartis, Forest For this specific article the reader should be aware that I have had financial arrangements with Pfizer, Eisai, Novartis and Janssen as listed above. They are the manufacturers of the acetylcholinesterase inhibitors. Pfizer is also the manufacturer of atorvastatin, a statin that is being investigated in AD and for which I have been a consultant.
Kannayiram Alagiakrishnan: In the last three years I have received research support from Janssen-Ortho.
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
